Breast cancer hypo-fractionated radiotherapy offers long-term tumour control

Effectiveness of sentinel lymph node surgery after chemotherapy in node-positive breast cancer

Extending adjuvant trastuzumab treatment time provided no additional benefit

Breast cancer genome sequencing identified HER2 mutations as targets for drug treatment

Cognitive problems may be present before chemotherapy in women with breast cancer

BEATRICE study, adjuvant bevacizumab did not improve invasive disease-free survival in triple-negative breast cancer

Phase III trial did not show superiority of eribulin compared with capecitabine in metastatic breast cancer

Potential targets and complications of apoptosis and necrosis

Personalised medicine in metastatic colorectal cancer

Prognostic signatures in colon cancer

Targeting the proteasome mechanism

Effect of hypoxia on cancer progression and adaptive response